Moderna says it has finished its application to U.S. drug regulators for full approval of its COVID-19 vaccine, while Pfizer and BioNTech have begun their application for their COVID-19 vaccine to be used as a booster shot.
“This BLA submission for our COVID-19 vaccine, which we began in June, is an important milestone in our battle against COVID-19 and for Moderna, as this is the first BLA submission in our company’s history,” Stéphane Bancel, Moderna’s CEO, said in an Aug. 25 statement, referring to the Biologics License Application.
